Yoh-chie Lu

Biography

Yoh-Chie Lu is Venture Partner to Vertex Ventures HC, a venture subsidiary of Temasek Holdings. Mr. Lu, the founder of Biosensors International Group Ltd, was its chairman and CEO from its inception to 2008. He retained his leadership position as chairman of the Group since January 2008 until his recent retirement. Mr. Lu has more than 30 years’ experience in the medical industry. Prior to starting Biosensors in 1990, Mr. Lu established Asia-based operations for the Medical Division of Gould Inc in Tokyo in 1978. In 1986, he participated in a management-led leveraged buyout of the division from Gould and he continued as president of the Asia-Pacific division through 1988. In the same year, Mr. Lu took the company public on the Nasdaq and it was subsequently sold to British Oxygen Corporation. He then served as president of Asia-Pacific with British Oxygen until 1990. In addition to Biosensors, Mr. Lu is active in both international and local medical arena as an entrepreneurial angel investor. Within the private equity arena, Mr. Lu is a General Partner at Majuven Pte Ltd; Foundry Singapore and a venture partner for medical sector at Vertex Ventures HC. Mr. Lu works closely with Singapore’s Agency for Science, Technology and Research (A*STAR), where he serves on the main committee of President’s Science and Technology Awards and is a member of Health and Biomedical Sciences International Advisory Council. Mr. Lu has been serving on Singapore’s Board of National Research Foundation (NRF) since February 2014 and most recently been appointed as the Chairman of NRF Audit Committee in April 2017. Mr. Lu received a B.S. from the University of California at Berkeley and an M.B.A. from the Thunderbird Graduate School of International Management in Arizona.

Research Interest

Medicine and Pharmaceutical